ALG14 p.Ser83Tyr
c.248C>A · rs767402341 · VCV1361709
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1456 | likely benign |
|---|---|---|
| REVEL | 0.088 | moderately benign-leaning |
| SaProt | LLR -8.94 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.2 | GERP -0.58, phastCons 0.82 |
| Regional constraint | o/e 1.06 | unconstrained · MANE · 90 kb · p 0.32 · regional, not allelic |
| Overall | ||
| CADD | 18.82 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.00667% | 14,997 |
| African / African-American | 0.00267% | 37,441 |
| European (non-Finnish) | 8.48e-05% | 1,179,871 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ALG14
- Protein
- p.Ser83Tyr
- Coding
- c.248C>A
- MANE Select
- NM_144988
- dbSNP
- rs767402341
- Type
- single nucleotide variant
- Location
- chr1:95064906 (GRCh38)
- Gene constraint
- LOEUF 1.055 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 91.06
Disease context
congenital myasthenic syndrome 15 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse faciesmyopathy, epilepsy, and progressive cerebral atrophy
For Congenital myasthenic syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive
- Onset
- Infancy, Neonatal
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- ALG14 p.Ala13Ser Uncertain significance ★★ ⚠ same condition
- ALG14 p.Arg104Gln Uncertain significance ★★ ⚠ same condition
- ALG14 p.Arg109Gln Uncertain significance ★★ ⚠ same condition
- ALG14 p.Asn61Asp Uncertain significance ★★ ⚠ same condition
- ALG14 p.Asn61Ser Uncertain significance ★★ ⚠ same condition
- ALG14 p.Asn82Ser Uncertain significance ★★ ⚠ same condition
- ALG14 p.Glu110Lys Uncertain significance ★★ same condition
- ALG14 p.Glu179Lys Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/alg14-p-ser83tyr (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown